ELAB vs ICE · rev $2.0M vs P/E 37, rev $7.28B
Elevai Labs, Inc. Common Stock (ELAB) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
ELAB currently screens at market cap $6.5M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the ELAB and ICE stock pages for the full models.
Not investment advice.